US equities
|
NVDA
$152.86
▲+1.26%
AMD
$490.88
▼-7.41%
MU
$727.25
▲+3.12%
SPCX
$139.63
▼-2.70%
MSFT
$514.98
▲+1.32%
SNDK
$799.95
▲+3.06%
AAPL
$349.71
▼-0.78%
AMZN
$269.39
▲+0.62%
NVDA
$152.86
▲+1.26%
AMD
$490.88
▼-7.41%
MU
$727.25
▲+3.12%
SPCX
$139.63
▼-2.70%
MSFT
$514.98
▲+1.32%
SNDK
$799.95
▲+3.06%
AAPL
$349.71
▼-0.78%
AMZN
$269.39
▲+0.62%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:GALT
Recent news which mentions NASDAQ:GALT
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024
August 13, 2024
Tickers
GALT
Tags
GALT
NASDAQ:GALT
Market News
From
InvestorPlace
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024
May 15, 2024
Tickers
GALT
Tags
Earnings Reports
Market News
GALT
From
InvestorPlace
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023
April 05, 2024
Tickers
GALT
Tags
Earnings Reports
Market News
GALT
From
InvestorPlace
Is Galectin Therapeutics a Good Cancer Stock to Own?
July 16, 2021
Tags
NASDAQ:GALT
From
StockNews.com